An Observational Study of Patients Living With Chronic Neurological Diseases
NCT05796037 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500000
Last updated 2024-11-20
Summary
TARGET-NEURO is an observational research study to conduct a comprehensive review of outcomes for patients living with chronic neurological diseases: Alzheimer's disease and related dementia (ADRD), mild cognitive impairment (MCI), Parkinson's disease (PD), and multiple sclerosis (MS).
Conditions
- Neurological Diseases or Conditions
- Dementia of Alzheimer Type
- Alzheimer Disease
- Mild Cognitive Impairment
- Parkinson Disease
- Multiple Sclerosis
Sponsors & Collaborators
-
Target PharmaSolutions, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-03-31
- Primary Completion
- 2038-12-31
- Completion
- 2038-12-31
More Related Trials
-
Efficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer's Disease Patients
NCT01350362 ·Status: COMPLETED ·Phase: PHASE2
-
The Pilot Study of Medical Device-Neuclare for Patients With Mild Cognitive Disorder and Early Dementia
NCT05633095 ·Status: UNKNOWN ·Phase: NA
-
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
NCT07169578 ·Status: RECRUITING ·Phase: PHASE3
-
INTERCEPTOR Project: From MCI to Dementia
NCT03834402 ·Status: COMPLETED
-
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
NCT02565511 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
A Study to Assess Safety and Tolerability and to Explore Efficacy of NSC001 in Mild to Moderate Alzheimer's Disease
NCT06995573 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of the Safety, Tolerability, and Pharmacodynamics of MK-8931 in Participants With Alzheimer's Disease (MK-8931-010 AM1 [P07820 AM1])
NCT01496170 ·Status: COMPLETED ·Phase: PHASE1
-
A First Time in Human Study of SNP318 as a Treatment for Neurodegenerative Diseases Including Alzheimer's Disease
NCT05792163 ·Status: COMPLETED ·Phase: PHASE1
-
Study of ARO-MAPT-SC in Healthy Subjects and Subjects With Early Alzheimer's Disease
NCT07221344 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
PMN310 in Patients With Early Alzheimer's Disease (PRECISE-AD)
NCT06750432 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413)
NCT04730635 ·Status: COMPLETED ·Phase: PHASE1
-
Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease
NCT00955422 ·Status: COMPLETED
-
A Phase 3 Study of NE3107 in Probable Alzheimer's Disease
NCT04669028 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease
NCT02907567 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Feasibility Study in Subjects With Mild to Moderate Alzheimer's Disease
NCT02560753 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pilot Clinical Study of CT1812 in Mild to Moderate Alzheimer's Disease Using EEG
NCT04735536 ·Status: COMPLETED ·Phase: PHASE2
-
Shanghai At Risk for Alzheimer's Disease: a Cohort Study
NCT05597410 ·Status: RECRUITING
-
A Multicenter Study on the Diagnosis and Intervention of New Biomarkers on the Prodromal Stage of Alzheimer's Disease
NCT04137926 ·Status: UNKNOWN ·Phase: NA
-
A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831
NCT03538522 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
NCT05552157 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
A Study to Test the Performance of the CogState Computerized Neuropsychological Battery in Patients With Alzheimer's Disease (0000-086)(COMPLETED)
NCT00777608 ·Status: COMPLETED ·Phase: PHASE1
-
A Survey Study of the Treatment and Outcome Management in Patients Diagnosed With Alzheimer's Disease
NCT00291421 ·Status: COMPLETED
-
A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023)
NCT00874939 ·Status: TERMINATED ·Phase: PHASE1
-
Lifestyle Intervention Program for Cognitive Impairment
NCT02741804 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
NCT00663936 ·Status: COMPLETED ·Phase: PHASE2